Overnight Health Care: Top biotech lobbyist sees industry under...
The Hill sat down with James Greenwood, the CEO of the Biotechnology Innovation Organization, to talk about the group's priorities with a Democratic House looming. Also today, a new bill from the incoming chairman and current ranking member of the Senate Finance Committee gives a hint at the committee's new direction next year.
from Biotech News
0 Comments